The Journey to JAKs: First-in-Class Drugs to Treat Alopecia Areata
Time: 11:45 am
day: Day Two
Details:
- Overviewing the science that provided the rationale for JAK inhibitors in Alopecia Areata
- Discussing biomarkers of treatment response and patient selection
- Looking ahead to the next-generation JAK inhibitors in Alopecia Areata
